- $90.06m
- $68.57m
- $0.13m
Brief: Predictive Oncology Reports Quarterly Loss of $0.48 Per Share
Brief: Predictive Oncology Reports Q3 2024 Financial Results And Provides Strategic Update
Predictive Oncology Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: Predictive Oncology Expands The Application Of Its Live-Cell Tumor Platform
Brief: Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
Brief: Predictive Oncology CEO To Present At The Bio International Convention 2024
Brief: Predictive Oncology Files For Mixed Shelf Offering Of Up To $200 Million- SEC Filing
Brief: Predictive Oncology Announces Progress With FluGen In Development Of First-Of-Its-Kind Intranasal Flu Vaccine
Brief: Fujifilm And Predictive Oncology Announce Collaboration
Brief: Predictive Oncology Q3 Net Income USD -3.2 Million
Brief: Predictive Oncology Completes Ai-Driven Study Of Ovarian Cancer With Upmc Magee-Womens Hospital
Brief: Predictive Oncology CFO Bob Myers To Resign Effective September 30
Brief: Predictive Oncology Announces Relocation Of Corporate Headquarters To Pittsburgh
Brief: Predictive Oncology Reports First Quarter 2023 Financial Results And Provides Business Update
Brief: Predictive Oncology Inc - On May 2, David S. Smith, Jd, Resigned As Director Of Predictive Oncology Inc, Effective Immediately
Brief: Predictive Oncology Appoints Pharma, Biotech And Digital Health Veteran Veena Rao, Phd, Mba, To Its Board Of Directors
Predictive Oncology falls after reverse stock split
Brief: Predictive Oncology Announces Reverse Stock Split
Brief: Predictive Oncology Adjourns Special Meeting Of Stockholders